Covered recipient · General Payments record
ELIZABETH MARY TOCCI
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,914.22
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $338.23 | 16 |
| Education | $79.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $137.82 | 4 |
| Amgen Inc. | $92.47 | 5 |
| ABBVIE INC. | $59.79 | 2 |
| Lilly USA, LLC | $36.83 | 2 |
| Regeneron Healthcare Solutions, Inc. | $29.12 | 1 |
| E.R. Squibb & Sons, L.L.C. | $24.16 | 1 |
| LEO Pharma Inc. | $23.97 | 1 |
| UCB, Inc. | $14.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.90 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229333 | CMS |
| ABBVIE INC. | $31.89 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229335 | CMS |
| Amgen Inc. | $13.22 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399418 | CMS |
| Amgen Inc. | $22.23 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399420 | CMS |
| Amgen Inc. | $16.04 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399422 | CMS |
| Amgen Inc. | $18.69 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399424 | CMS |
| Amgen Inc. | $22.29 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117399426 | CMS |
| E.R. Squibb & Sons, L.L.C. | $24.16 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101472975 | CMS |
| Janssen Biotech, Inc. | $8.65 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078701756 | CMS |
| Janssen Biotech, Inc. | $36.34 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078701764 | CMS |
| Janssen Biotech, Inc. | $12.84 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078701752 | CMS |
| Janssen Biotech, Inc. | $79.99 | 11/27/2024 | Education | Undisputed | 01/23/2026 | 1078701760 | CMS |
| LEO Pharma Inc. | $23.97 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152653925 | CMS |
| Lilly USA, LLC | $13.16 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134969867 | CMS |
| Lilly USA, LLC | $23.67 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136165814 | CMS |
| Regeneron Healthcare Solutions, Inc. | $29.12 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114219834 | CMS |
| UCB, Inc. | $14.06 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143422101 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.